Company News & Press

Media, Press, and other Proxima Company Updates

Newsletter: Texas Two-Step: Back To Square One | May 24th, 2022

Proxima Clinical Research Client, Airway Shield™, Receives STeP Designation for Endotracheal Intubation Device that Protects Patients and Clinicians

Kevin Coker: Here's How to Maintain Customer Service, Even When You're Short-Staffed

Proxima Clinical Research Earns 2022 Great Place to Work® Certification Amid Continued Growth and Promotions

Kevin Coker: How to Strategically Plan Your International Business Expansion

Newsletter: Brains, Bubbles, & BDD | May 9th, 2022

Proxima Clinical Research Honored by Hermes Creative Awards

Newsletter: Poison Pills & Contingency Plans | April 26th, 2022

Proxima Growth 2022: People and Business News in Applied Clinical Trials

Houston Innovation Map: Houston-based synthetic biology investment fund taps 2 prominent advisers for board

Newsletter: Twitter, Tesla & Things Not to Do Unless You are a Trillionaire (on a Tuesday no less) | April 12th, 2022

Kevin Coker: Three Pieces Of Advice For Entrepreneurs Navigating Seed Funding

Proxima Newsletter

Rants, raves and observations.
Occasionally an opinion or fact.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Expertise

Resources

Company

Company Updates

Connect

2450 Holcombe Blvd.
Houston, TX 77021

Hello@ProximaCRO.com
+1.281.306.3127

Proxima Clinical Research, Inc. (aka Proxima CRO) is a registered Delaware C Corp, headquartered in Houston, TX
© Copyright 2025 Proxima Clinical Research, Inc. All Rights Reserved.